Breaking News, Collaborations & Alliances

Scilex Pharmaceuticals Gets Backing From Itochu Chemical Frontier

Investment by ICF is its first in a US pharma company

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Scilex Pharmaceuticals, Inc., a company engaged in the development and commercialization of products focused on the treatment of pain, announced that Itochu Chemical Frontier Corporation (ICF) of Tokyo, Japan, and a member of Itochu Corporation, one of the three leading general trading companies in Japan, has made a strategic investment in Scilex. ICF has worked closely with Scilex as an advisor and development partner for its flagship product under development, ZTlid, since 2013. This investmen...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters